Which Minimally Invasive Therapy Is Most Effective For The Treatment Of Postherpetic Neuralgia? An Updated Network Meta-Analysis

Bei Wen,Yuguang Huang,Li Xu

DOI: https://doi.org/10.1016/j.jpain.2023.02.146

2023-04-01

Abstract:Postherpetic neuralgia (PHN) is the most common and annoying complication of herpes zoster, which significantly reduces patients' quality of life. Minimally invasive therapies are commonly needed because drug therapy alone is not always effective, particularly for the elderly and patients with long-term pain. To figure out which interventional therapy is most effective, we first performed a paired meta-analysis, followed by a Bayesian network meta-analysis with direct or indirect comparisons for nine different therapies. After searching, 283 studies were found, and 14 were included for analysis. We found that short-term spinal cord stimulation (SCS) is the most effective individual therapy a month, three months, six months, and a year after the treatment, followed by pulsed radiofrequency (PRF), BTX-A therapy, nerve block (NB), and subcutaneously injection (SC). The addition of dexamethasone injection could prompt the efficacy of PRF better than SCS. After the treatment of a month, PRF+NB was more effective than SCS, but SCS surpassed the former after three and six months. Interestingly, SC alone could not alleviate the pain after the treatment of 2 weeks and a month, but after three months, the pain was mitigated. In conclusion, for patients suffering from PHN, using minimally invasive therapies such as SCS and PRF based on regular administration of anti-neuropathic pain drugs seems to be a better choice. The combination of PRF with dexamethasone or local anesthetics can achieve a better curative effect.Funding: NSFC (82271262; 82071252); the Fundamental Research Funds for the Central Universities (3332020120) NSFC (82271262; 82071252); the Fundamental Research Funds for the Central Universities (3332020120).

neurosciences,clinical neurology